Skip to content

Investors / Contact


Contact Information

FOR INVESTORS
Elisabeth Schwartz
Email: investor.relations@amarincorp.com
FOR ADVERSE EVENTS RELATED TO VASCEPA
Email: AmarinMI@druginfo.com
Phone: 1-855-VASCEPA, 1-855-827-2372